VKH
ACHN

Virtu KCG Holdings’s Achillion Pharmaceuticals ACHN Stock Holding History

Virtu KCG Holdings’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-98,195
Closed -$413K – 3754
2017
Q1 		$413K Buy
98,195
+40,766
+71% +$169K 0.01% 1574
2016
Q4 		$237K Buy
57,429
+42,688
+290% +$227K 0.01% 2379
2016
Q3 		$119K Sell
14,741
-39,564
-73% -$336K ﹤0.01% 2584
2016
Q2 		$424K Buy
54,305
+25,462
+88% +$218K 0.01% 1529
2016
Q1 		$223K Buy
28,843
+9,673
+50% +$70.8K 0.01% 1989
2015
Q4 		$207K Sell
19,170
-9,102
-32% -$82.7K ﹤0.01% 2671
2015
Q3 		$195K Buy
28,272
+15,714
+125% +$128K ﹤0.01% 2585
2015
Q2 		$111K Sell
12,558
-17,194
-58% -$163K ﹤0.01% 2868
2015
Q1 		$293K Buy
+29,752
New +$372K 0.01% 1949
2014
Q4 		– Sell
-66,155
Closed -$660K – 4405
2014
Q3 		$660K Buy
+66,155
New +$614K 0.01% 1386
2014
Q2 		– Sell
-37,282
Closed -$122K – 4205
2014
Q1 		$122K Buy
37,282
+23,232
+165% +$81.3K ﹤0.01% 3156
2013
Q4 		$47K Sell
14,050
-1,606
-10% -$4.66K ﹤0.01% 3608
2013
Q3 		$47K Buy
+15,656
New +$107K ﹤0.01% 3519

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Virtu KCG Holdings's ACHN Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Achillion Pharmaceuticals (ACHN) in Q2 2017, closing a stake of 98,195 shares — an estimated $413K sold.

Virtu KCG Holdings first reported a position in ACHN in Q3 2013 and held it in 13 quarters. The position peaked at $660K in Q3 2014. 129 funds tracked by Wall St. Rank hold ACHN as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Achillion Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 98,195 Achillion Pharmaceuticals shares in Q2 2017, an estimated $413K.
  • Virtu KCG Holdings first reported a position in Achillion Pharmaceuticals in Q3 2013 and held it in 13 quarters.
  • Virtu KCG Holdings's Achillion Pharmaceuticals position peaked at $660K in Q3 2014.
  • 129 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.